{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:22Z","timestamp":1753891102855,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771844, 82371981"],"award-info":[{"award-number":["81771844, 82371981"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Parathyroid carcinoma (PC) and atypical parathyroid tumor (APT) are rare malignant parathyroid disorders with varying degrees of recurrence risk. The aim of this study was to determine an effective model for discriminating PC\/APT among solitary parathyroid lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 439 patients with histologically confirmed primary hyperparathyroidism were retrospectively enrolled. The training cohort comprised 207 patients, the validation cohort comprised 52 patients from Hospital I, and the external validation cohort comprised 180 patients from Hospital II. All patients were diagnosed in the parathyroid adenoma (PA) group and the APT\/PC group. The clinical and ultrasonic features of the two patient groups were compared. Multivariate logistic regression analysis was conducted to identify independent risk factors for APT\/PC. A nomogram was built based on multivariate logistic regression analysis. Model discrimination was assessed using receiver operating characteristic (ROC) curve analysis. The area under the curve (AUC), sensitivity, specificity, and accuracy were reported. Decision and calibration curve analyses were performed to assess the clinical value and calibration of each model, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the training set, there were 181 cases of PA and 26 cases of APC\/PC. Intact parathyroid hormone (iPTH) [odds ratio (OR): 1.019, 95% confidence interval (CI): 1.008\u20131.032], shape (OR: 16.625, 95% CI: 5.922\u201351.883), and relation with the thyroid capsule (OR: 3.422, 95% CI: 1.455\u20139.152) were independent predictive factors associated with the risk of APT\/PC. The AUCs for training and internal and external validation were 0.929, 0.962, and 0.965, respectively. The accuracy, sensitivity, and specificity were 86%, 96%, and 85% in the training cohort; 92%, 100%, and 90% in the validation cohort; and 88%, 100%, and 88% in the external validation cohort, respectively. In addition, calibration plots graphically showed good agreement in the presence of the APT\/PC group between risk estimation by the nomogram and histopathologic confirmation of surgical specimens. DCA in the current study showed that the nomogram was more effective than all-patient treatment or no treatment over a wide range of threshold probabilities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Ultrasonic features in combination with iPTH levels may be an applicable model for predicting potentially malignant parathyroid tumors and has a better potential to facilitate preoperative decision-making.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1538361","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:00:04Z","timestamp":1743764404000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study on a nomogram combining clinical and ultrasound parameters for differentiating solitary parathyroid adenoma from carcinoma or atypical tumors"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunrui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4322-7","article-title":"Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016","volume":"29","author":"Sun","year":"2018","journal-title":"Osteoporos Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0195","article-title":"Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centre\u2019s experience","volume":"7","author":"Reid","year":"2018","journal-title":"Endocr Connect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: an update","volume":"86","author":"Rodrigo","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.102","article-title":"Diagnosis and management of parathyroid cancer","volume":"8","author":"Schulte","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","article-title":"Update on parathyroid carcinoma","volume":"39","author":"Cetani","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-019-09592-3","article-title":"Using a novel diagnostic nomogram to differentiate Malignant from benign parathyroid neoplasms","volume":"30","author":"Silva-Figueroa","year":"2019","journal-title":"Endocr Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196297","article-title":"Parathyroid retrospective analysis of neoplasms incidence (pTRANI Study): an Italian multicenter study on parathyroid carcinoma and atypical parathyroid tumour","volume":"12","author":"Gurrado","year":"2023","journal-title":"JCM"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000224","article-title":"Evaluation of preoperative ultrasonographic and biochemical features of patients with aggressive parathyroid disease: is there a reliable predictive marker","volume":"60","author":"Cakir","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06707-9","article-title":"How nuclear imaging changed parathyroid surgical strategies through time","volume":"51","author":"Schouw","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-19-7919-4","volume-title":"Atlas of Sonography of Parathyroid","author":"Singhal","year":"2023"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2019.07.02","article-title":"Semi-quantitative analysis of 99mTc-sestamibi retention level for preoperative differential diagnosis of parathyroid carcinoma","volume":"9","author":"Zhang","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2023.104155","article-title":"Comparing accuracy of machine learning approaches to identifying parathyroid adenomas: Lessons and new directions","volume":"45","author":"Greene","year":"2024","journal-title":"Am J Otolaryngol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261900","article-title":"Diagnostic performance of cervical ultrasound, 99m Tc-Sestamibi scintigraphy, and contrast-enhanced 18 F-Fluorocholine PET in primary hyperparathyroidism","volume":"63","author":"Boudousq","year":"2022","journal-title":"J Nucl Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02069-7","article-title":"Ultrasound combined with biochemical parameters can predict parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"66","author":"Liu","year":"2019","journal-title":"Endocrine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-022-00503-0","article-title":"Shear wave elastography for differentiating parathyroid neoplasms with Malignant diagnosis or uncertain Malignant potential from parathyroid adenomas: initial experience","volume":"22","author":"Liu","year":"2022","journal-title":"Cancer Imaging"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio","article-title":"Development and validation of an explainable machine learning model for identification of hyper-functioning parathyroid glands from high-frequency ultrasonographic images","volume":"50","author":"Zhou","year":"2024","journal-title":"Ultrasound Med Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad527","article-title":"Sonographic features of atypical and initially missed parathyroid adenomas: lessons learned from a single-center cohort","volume":"109","author":"Ilgan","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100751","article-title":"Differentiating pathologic parathyroid glands from thyroid nodules on neck ultrasound: the PARATH-US cross-sectional study","volume":"35","author":"Yazgi","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-021-02179-9","article-title":"Predictors of adenoma size and location in primary hyperparathyroidism","volume":"406","author":"Filser","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","article-title":"Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting","volume":"110","author":"Williams","year":"2021","journal-title":"Hum Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14807","article-title":"Early diagnosis of parathyroid carcinoma: A challenging for physicians","volume":"98","author":"Campenn\u00ec","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3745239","article-title":"The clinical features of cystic parathyroid adenoma in Chinese population: a single-center experience","volume":"2018","author":"Hu","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122851","article-title":"Discriminating parathyroid adenoma from local mimics by using inherent tissue attenuation and vascular information obtained with four-dimensional CT: formulation of a multinomial logistic regression model","volume":"270","author":"Hunter","year":"2014","journal-title":"Radiology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.11.29","article-title":"A new tool for diagnosing parathyroid lesions: angio plus ultrasound imaging","volume":"11","author":"Liu","year":"2019","journal-title":"J Thorac Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26677","article-title":"Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort","volume":"43","author":"Shah","year":"2021","journal-title":"Head Neck"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1538361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:00:09Z","timestamp":1743764409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1538361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":28,"alternative-id":["10.3389\/fendo.2025.1538361"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1538361","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1538361"}}